Table 2.
Concurrent administration of rotavirus and pentavalenta vaccines among children born in 2007–2009. El Salvador, 2011.
| Year of birth |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total |
2007 (N = 806) |
2008 (N = 877) |
2009 (N = 809) |
||||||||||
| n | % | CI | n | % | CI | n | % | CI | n | % | CI | ||
| Rotavirus dose 1 (N = 2338) |
With penta1b | 1814 | 77.2 | (75.0, 79.4) | 592 | 80.6 | (77.5, 83.7) | 701 | 84.4 | (81.8, 87.0) | 521 | 66.4 | (62.2, 70.7) |
| With penta2c | 166 | 7.4 | (6.1, 8.6) | 50 | 7.2 | (5.1, 9.2) | 34 | 4.1 | (2.6, 5.7) | 83 | 11.0 | (8.5, 13.5) | |
| In a separate visit | 358 | 15.4 | (13.7, 17.2) | 90 | 12.3 | (9.5, 15.1) | 97 | 11.4 | (9.2, 13.7) | 171 | 22.6 | (19.0, 26.1) | |
| Rotavirus dose 2 (N = 2162) | With penta2 | 1613 | 74.8 | (72.8, 76.9) | 542 | 77.9 | (74.6, 81.3) | 610 | 80.9 | (77.5, 84.2) | 461 | 66.5 | (61.6, 69.4) |
| With penta3d | 95 | 4.8 | (3.7, 5.9) | 20 | 2.9 | (1.6, 4.3) | 19 | 2.4 | (1.3, 3.6) | 56 | 9.1 | (6.2, 12.0) | |
| In a separate visit | 454 | 20.4 | (18.6, 22.2) | 138 | 19.1 | (16.0, 22.3) | 125 | 16.7 | (13.6, 19.8) | 191 | 25.4 | (22.0, 28.9) | |
a
Diphtheria–tetanus–pertussis–Hepatitis B–Haemophilus influenzae type b vaccine.
b
Penta1 is the first dose of pentavalent vaccine.
c
Penta2 is the second dose of pentavalent vaccine.
d
Penta2 is the second dose of pentavalent vaccine.